These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2009145)

  • 41. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of the angiotensin-converting enzyme inhibitor perindopril on 24-hour blood pressure in patients with lacunar infarction: comparison between dippers and non-dippers.
    Yamamoto Y; Oiwa K; Hayashi M; Ohara T; Muranishi M
    Hypertens Res; 2005 Jul; 28(7):571-8. PubMed ID: 16335885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects on urinary albumin excretion and renal function changes by delapril and manidipine in normotensive type 2 diabetic patients with microalbuminuria.
    Deerochanawong C; Kornthong P; Phongwiratchai S; Serirat S
    J Med Assoc Thai; 2001 Feb; 84(2):234-41. PubMed ID: 11336083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of manidipine and delapril on insulin sensitivity in type 2 diabetic patients with essential hypertension.
    Suzuki S; Ohtomo M; Satoh Y; Kawasaki H; Hirai M; Hirai A; Hirai S; Onoda M; Hinokio Y; Akai H; Toyota T
    Diabetes Res Clin Pract; 1996 Jun; 33(1):43-51. PubMed ID: 8877275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of delapril on stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
    Inada Y; Ojima M; Itoh K; Shino A; Nishikawa K
    Drugs Exp Clin Res; 1995; 21(2):41-9. PubMed ID: 7555608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial.
    Ruggenenti P; Lauria G; Iliev IP; Fassi A; Ilieva AP; Rota S; Chiurchiu C; Barlovic DP; Sghirlanzoni A; Lombardi R; Penza P; Cavaletti G; Piatti ML; Frigeni B; Filipponi M; Rubis N; Noris G; Motterlini N; Ene-Iordache B; Gaspari F; Perna A; Zaletel J; Bossi A; Dodesini AR; Trevisan R; Remuzzi G;
    Hypertension; 2011 Nov; 58(5):776-83. PubMed ID: 21931073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetic and pharmacologic properties of delapril, a lipophilic nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Razzetti R; Acerbi D
    Am J Cardiol; 1995 Jun; 75(18):7F-12F. PubMed ID: 7778536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circadian heart rate variability in patients with primary arterial hypertension.
    Kolasińska-Kloch W; Furgała A; Banach T; Laskiewicz J; Thor PJ
    Przegl Lek; 2002; 59(9):752-5. PubMed ID: 12632903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing.
    Hermida RC; Ayala DE
    Hypertension; 2009 Jul; 54(1):40-6. PubMed ID: 19433778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Delapril plus indapamide: a review of the combination in the treatment of hypertension.
    Cavalieri L; Cremonesi G
    Clin Drug Investig; 2007; 27(6):367-80. PubMed ID: 17506588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [24-hour ambulatory monitoring of blood pressure in patients with essential hypertension: the effectiveness of enalapril therapy].
    Siegelová J; Fiser B; Dusek J
    Vnitr Lek; 1996 Feb; 42(2):98-101. PubMed ID: 8686198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioavailability and pharmacokinetics of a fixed combination of delapril/indapamide following single and multiple dosing in healthy volunteers.
    Hutt V; Pabst G; Dilger C; Poli G; Acerbi D
    Eur J Drug Metab Pharmacokinet; 1994; 19(1):59-69. PubMed ID: 7957454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.
    Mancia G; Omboni S; Chazova I; Coca A; Girerd X; Haller H; Parati G; Pauletto P; Pupek-Musialik D; Svyshchenko Y;
    J Hypertens; 2016 Jan; 34(1):139-48. PubMed ID: 26630216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension].
    Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV
    Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics and tolerability of a new manidipine and delapril fixed oral combination in young and elderly subjects.
    Stockis A; De Bruyn S; Gengler C; Goethals F; Lens S; Poli G; Acerbi D
    Arzneimittelforschung; 2003; 53(8):554-61. PubMed ID: 13677245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
    Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
    Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.